Venn diagram analysis revealed that there was very little overlap between the total upregulated genes in FLX-treated and anti-PD-1-treated tumor-infiltrating CD8 T cells (21/432 and 21/110, respectively; Figure 2I). The gene discussed is CD8A; the disease is neoplasm.